The association with ERBB signaling pathways among negatively correlated genes points to a potential compensatory mechanism in more aggressive tumor subtypes, where alternative oncogenic pathways might become activated in response to changes in CCND1 expression. This evidence concerns the gene CCND1 and neoplasm.